|
| 1 |
Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis
Ting Xu, Xicheng Wang, Ying Xin, Zhenghang Wang, Jifang Gong, Xiaotian Zhang, Yanyan Li, Congcong Ji, Yu Sun, Feilong Zhao, Depei Huang, Yuezong Bai, Jian Li, Lin Shen
Cancer Res Treat.2023;55(2):626-635. Published online 2022 December 23
DOI: http://dx.doi.org/10.4143/crt.2022.1058
|
|
| 2 |
Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer
Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.2022;54(4):1130-1137. Published online 2022 January 17
DOI: http://dx.doi.org/10.4143/crt.2021.1103
|
|
| 3 |
Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2–Targeted Agent in the Real-World Setting
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, Heejung Chae, Eo Jin Kim, Mee-Sun Moon, Yoon-Koo Kang
Cancer Res Treat.2021;53(2):436-444. Published online 2020 October 6
DOI: http://dx.doi.org/10.4143/crt.2020.725
|
|
| 4 |
Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection
Mikel Prieto, Mikel Gastaca, Patricia Ruiz, Alberto Ventoso, Ibone Palomares, Arkaitz Perfecto, Andrés Valdivieso
|
|
| 5 |
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
Sung-Bae Kim, In-Gu Do, Janice Tsang, Tae-You Kim, Yoon-Sim Yap, Gerardo Cornelio, Gyungyub Gong, Soonmyung Paik, Suee Lee, Ting-Ying Ng, Sarah Park, Ho-Suk Oh, Joanne Chiu, Joohyuk Sohn, Moonhee Lee, Young-Jin Choi, Eun Mi Lee, Kyong-Hwa Park, Christos Nathaniel, Jungsil Ro
Cancer Res Treat.2019;51(4):1527-1539. Published online 2019 June 4
DOI: http://dx.doi.org/10.4143/crt.2018.598
|
|
| 6 |
Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study
Kyubo Kim, Kyung Hwan Shin, Jin Ho Kim, Doo Ho Choi, Won Park, Yong Bae Kim, Hyun Ju Kim, Jin Hee Kim, Hyeli Park, Sun Young Lee, Jiyoung Kim, Do Hoon Oh, In Ah Kim
J Breast Cancer.2019;22(1):120-130. Published online 2018 December 20
DOI: http://dx.doi.org/10.4048/jbc.2019.22.e1
|
|
| 7 |
Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data
Sun Hyong You, Byung Joo Chae, Yong Hwa Eom, Tae-Kyung Yoo, Yong-seok Kim, Jeong Soo Kim, Woo-Chan Park
J Breast Cancer.2018;21(4):415-424. Published online 2018 November 23
DOI: http://dx.doi.org/10.4048/jbc.2018.21.e53
|
|
| 8 |
Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data
Eun Kyoung Kim, Jinhyun Cho, Ji-Yeon Kim, Sung-A Chang, Sung-Ji Park, Jin Oh Choi, Sang Chol Lee, Jin Seok Ahn, Seung Woo Park, Young-Hyuck Im, Eun Seok Jeon, Yeon Hee Park
Cancer Res Treat.2019;51(2):727-736. Published online 2018 September 4
DOI: http://dx.doi.org/10.4143/crt.2018.262
|
|
| 9 |
FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment
Heejung Chae, Changhoon Yoo, Jung-A Yoon, Hee Jin Lee, Kyu-pyo Kim, Jeong-Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Gyungyub Gong, Sung-Bae Kim
|
|
| 10 |
Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab
In-Ho Kim, Ji Eun Lee, Ho-Joong Youn, Byung Joo Song, Byung Joo Chae
|
|
| 11 |
Trastuzumab Exposure during Pregnancy with Invasive Breast Cancer
Joon Won Min, Yun Dan Kang
Perinatology.2017;28(4):184-186. Published online 2017 January 19
DOI: http://dx.doi.org/10.14734/PN.2017.28.04.184
|
|
| 12 |
Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer
Hyun Ju Yoon, Kye Hun Kim, Jong Yoon Kim, Hyuk Jin Park, Jae Yeong Cho, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park
J Breast Cancer.2016;19(4):402-409. Published online 2016 December 23
DOI: http://dx.doi.org/10.4048/jbc.2016.19.4.402
|
|
| 13 |
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, Hee Kyung Ahn, Hyun Jin Baek, Soon Il Lee, Do Hyoung Lim, Young-Woong Won, Jun Ho Ji, Hyo Song Kim, Sun Young Rha, Sung Yong Oh, Kyung Eun Lee, Taekyu Lim, Chi Hoon Maeng, Moon Jin Kim, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park
Cancer Res Treat.2016;48(2):553-560. Published online 2015 August 10
DOI: http://dx.doi.org/10.4143/crt.2015.155
|
|
| 14 |
Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis
Won-Young Park, Han-Jo Kim, Kyoungha Kim, Sang-Byung Bae, Namsu Lee, Kyu-Taek Lee, Jong-Ho Won, Hee-Sook Park, Sang-Cheol Lee
Cancer Res Treat.2016;48(2):843-847. Published online 2015 March 2
DOI: http://dx.doi.org/10.4143/crt.2014.234
|
|
| 15 |
Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab Compared to Standard Trastuzumab-Based Chemotherapy Regimens for Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Potjana Jitawatanarat, Tracey L. O'Connor, Ellen B. Kossoff, Ellis G. Levine, Kaweesak Chittawatanarat, Nuttapong Ngamphaiboon
J Breast Cancer.2014;17(4):356-362. Published online 2014 December 26
DOI: http://dx.doi.org/10.4048/jbc.2014.17.4.356
|
|
| 16 |
Risk of Trastuzumab-Related Cardiotoxicity in Early Breast Cancer Patients: A Prospective Observational Study
Jian Xue, Zefei Jiang, Fan Qi, Shuanghong Lv, Shaohua Zhang, Tao Wang, Xiaozhong Zhang
J Breast Cancer.2014;17(4):363-369. Published online 2014 December 26
DOI: http://dx.doi.org/10.4048/jbc.2014.17.4.363
|
|
| 17 |
Trastuzumab-Conjugated Liposome-Coated Fluorescent Magnetic Nanoparticles to Target Breast Cancer
Mijung Jang, Young Il Yoon, Yong Soo Kwon, Tae-Jong Yoon, Hak Jong Lee, Sung Il Hwang, Bo La Yun, Sun Mi Kim
|
|
| 18 |
Early Cardiac Function Monitoring for Detection of Subclinical Doxorubicin Cardiotoxicity in Young Adult Patients with Breast Cancer
Woo-Baek Chung, Jeong-Eun Yi, Jung Yeon Jin, Yun-Seok Choi, Chan Seok Park, Woo-Chan Park, Byung Joo Song, Ho-Joong Youn
|
|
| 19 |
Psoriasis Induced by Trastuzumab (Herceptin®)
Dae Hun Kim, Nam Ji Jeong, Myung Im, Young Lee, Young Joon Seo, Jeung Hoon Lee
|
|
| 20 |
The Predictive Value of Serum HER2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy
Jung Sun Lee, Byung-Ho Son, Sei Hyun Ahn
|
|
